Showing 4481-4490 of 5771 results for "".
- Myopia Profile and Essilor Partner to Tackle Childhood Myopia Through Education and Awarenesshttps://modernod.com/news/myopia-profile-and-essilor-partner-to-tackle-childhood-myopia-through-education-and-awareness/2478446/Myopia educational company Myopia Profile and Essilor International announced their partnership to provide eye care practitioners with clinical knowledge, skills and practice in managing childhood myopia. The partnership will also see a boost to public awareness of the consequences of myopia, als
- FundamentalVR Expands Into Ophthalmologyhttps://modernod.com/news/fundamentalvr-expands-into-ophthalmology/2478436/FundamentalVR, a provider of VR surgical skills training and skills data analytics, announced the expansion of its surgical specialty capabilities with the addition of ophthalmology. Powered by the company’s patented HapticVR technology architecture that mimics the physical cues of surgical actio
- Nevakar Enters into Licensing Agreement in China for NVK-002 for the Treatment of Myopia in Childrenhttps://modernod.com/news/nevakar-enters-into-licensing-agreement-in-china-for-nvk-002-for-the-treatment-of-myopia-in-children/2478434/Nevakar and Hong Kong-based Zhaoke Ophthalmology Pharmaceutical (ZKO) announced have entered into an exclusive licensing agreement for the development and commercialization of Nevakar’s NVK-002 in Greater China, Hong Kong SAR, Macau SAR and Taiwan, South Korea and the Southeast Asian territories.
- Katena Products Acquires Micro-Select Instrumentshttps://modernod.com/news/katena-products-acquires-micro-select-instruments/2478435/Katena Products announced the purchase of Micro-Select Instruments, a maker of ophthalmic instruments including forceps, needle holders, and speculums. Terms of the deal were not disclosed. “The acquisition of Micro-Select is an important addition to Katena’s growing instrument manu
- Biotech Healthcare Launches Bio-Hyalur LVD for Tranquil Surgeries, Calm & Clear Eyeshttps://modernod.com/news/biotech-healthcare-launches-bio-hyalur-lvd-for-tranquil-surgeries-calm-clear-eyes/2478424/Biotech Healthcare announced the launch in Europe of Bio-Hyalur LVD, a combination of cohesive and dispersive viscoelastic solution. It is a mix of hyaluronic acid (3%) and chondroitin sulfate (4%), enabling space maintenance and protection to endothelium, according to a company news release.
- BVI Acquires Benz Research & Development, Strengthening IOL Design, Production and Sales Capabilitieshttps://modernod.com/news/bvi-acquires-benz-research-development-strengthening-iol-design-production-and-sales-capabilities/2478419/BVI announced its recent completion of the acquisition of Benz Research & Development and its customized contact lens subsidiary, SpecialEyes, both based in Sarasota, Florida. Terms of the deal were not disclosed. The Benz portfolio of performanc
- Regeneron’s Inmazeb Becomes First FDA-Approved Treatment for Ebola Virushttps://modernod.com/news/regenerons-inmazeb-becomes-first-fda-approved-treatment-for-ebola-virus/2478420/The FDA announced Wednesday that it has approved Regeneron Pharmaceuticals’ triple antibody cocktail Inmazeb (atoltivimab/maftivimab/odesivimab-ebgn) for use in adult and paediatric patients, making it the first drug cleared in the US to treat Ebola virus infection. According to the a
- New Orbis International Training Tool Prepares Ophthalmic Nurses for the Operating Roomhttps://modernod.com/news/new-orbis-international-training-tool-prepares-ophthalmic-nurses-for-the-operating-room/2478417/Orbis International announced the publication of the Orbis Ophthalmic Nursing Competency Assessment Rubric (ONCAR) for scrub nurses and technicians in Insight, the American Society of Ophthalmic Registered Nurses’ peer-reviewed clinical journal. The ONCAR is the first published tool
- New World Medical Registers New KDB GLIDE for Smooth, Precise Goniotomyhttps://modernod.com/news/new-world-medical-registers-new-kdb-glide-for-smooth-precise-goniotomy/2478414/New World Medical announced FDA registration of the KDB GLIDE as a Class 1 device, designed to give surgeons a refined, precise experience performing excisional goniotomy for treatment of glaucoma. The KDB GLIDE device improves on the successful Kahook Dual Blade technology by adding new features
- Tepezza Data From Phase 2 Clinical Trial Evaluate Longer-Term Responses in People Living with Thyroid Eye Disease (TED)https://modernod.com/news/tepezza-data-from-phase-2-clinical-trial-evaluate-longer-term-responses-in-people-living-with-thyroid-eye-disease-ted/2478415/Horizon Therapeutics announced new long-term follow-up data from the phase 2 clinical trial of Tepezza (teprotumumab-trbw), which showed a sustained response up to 1 year following completion of treatment for Thyroid Eye Disease (TED). These data will be presented as part of the